Victoza: cost and payments to doctors
What Medicare Part D paid pharmacies for Victoza, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Part D cost for Victoza formulations
Medicare reports Victoza under its specific formulations, which are priced separately.
- victoza 3 pak$722per 30-day fill · 44,376 claims · Liraglutide
- victoza 2 pak$584per 30-day fill · 27,346 claims · Liraglutide
Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?
Was your doctor paid by Novo Nordisk?
Novo Nordisk reported the most payments naming Victoza. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $3.2M
- Providers
- 12,701
- Transactions
- 42,529
- Average per transaction
- $76
The per-transaction average — $76 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,701 providers the average total is $254, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novo Nordisk | $3,027,567 | 93.7% |
| Novo Nordisk AS | $204,502 | 6.3% |
Other products from Novo Nordisk
The company that reported the most payments naming Victoza also reports against these.
- Ozempic$68,960,665
- RYBELSUS$52,214,661
- Wegovy$25,962,654
- Saxenda$11,211,470
- Tresiba$7,105,945
- Norditropin$1,595,322
- Xultophy 100/3.6$1,383,782
- Sogroya$1,161,676
- REBINYN$524,493
- Esperoct$518,576